Clinical Trials Sponsored by SanBio, Inc.
Total 36054 results
-
Daiichi Sankyo, Inc.CompletedPharmacokinetics | Tolerability | SafetyUnited Kingdom
-
Daiichi Sankyo, Inc.WithdrawnPulmonary Embolism
-
Daiichi Sankyo, Inc.CompletedDrug InteractionUnited Kingdom
-
Daiichi Sankyo, Inc.Completed
-
Daiichi Sankyo, Inc.Completed
-
Daiichi Sankyo, Inc.TerminatedMetastatic Breast CancerChile, Argentina
-
Daiichi Sankyo, Inc.Completed
-
Daiichi Sankyo, Inc.CompletedType 2 Diabetes | HyperlipidemiaUnited States
-
Daiichi Sankyo, Inc.TerminatedStrokeUnited States, Israel, Poland, Spain, Belgium, Germany, South Africa
-
Daiichi Sankyo, Inc.CompletedHypercholesterolemiaUnited States
-
Daiichi Sankyo, Inc.CompletedHypercholesterolemiaUnited States
-
Daiichi Sankyo, Inc.CompletedAdvanced Solid Malignant Tumors | Advanced Ovarian CancerUnited States
-
Daiichi Sankyo, Inc.Completed
-
Daiichi Sankyo, Inc.CompletedColorectal Cancer | Solid Tumor | Endometrial CancerUnited States
-
Daiichi Sankyo, Inc.CompletedMetastatic Colorectal CancerUnited States
-
Daiichi Sankyo, Inc.Completed
-
Daiichi Sankyo, Inc.Completed
-
Daiichi Sankyo, Inc.Completed
-
Daiichi Sankyo, Inc.Completed
-
Daiichi Sankyo, Inc.CompletedColorectal CancerUnited States
-
Daiichi Sankyo, Inc.CompletedLymphoma | Unspecified Childhood Solid Tumor, Protocol Specific | Brain and Central Nervous System TumorsUnited States
-
Daiichi Sankyo, Inc.CompletedCervical CancerUnited States
-
Daiichi Sankyo, Inc.CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited States
-
Daiichi Sankyo, Inc.TerminatedMetastatic Colorectal CancerUnited Kingdom
-
Daiichi Sankyo, Inc.Completed
-
Daiichi Sankyo, Inc.Completed
-
Daiichi Sankyo, Inc.Completed
-
Daiichi Sankyo, Inc.CompletedType 2 Diabetes MellitusUnited States
-
Daiichi Sankyo, Inc.TerminatedSymptomatic Hip OsteoarthritisFrance
-
Daiichi Sankyo, Inc.CompletedDiabetes Mellitus, Type 2United States
-
Daiichi Sankyo, Inc.CompletedHypertension | Metabolic Syndrome | Insulin ResistanceUnited States
-
Daiichi Sankyo, Inc.Completed
-
Sankyo Pharma GmbhCompleted
-
Sankyo Pharma GmbhCompleted
-
Daiichi Sankyo, Inc.Completed
-
Daiichi Sankyo, Inc.CompletedTenosynovial Giant Cell TumorUnited States, Spain, Taiwan, Australia, Hungary, Italy, Netherlands
-
Daiichi Sankyo, Inc.Completed
-
Daiichi Sankyo, Inc.CompletedNetherton SyndromeUnited States
-
Daiichi Sankyo, Inc.CompletedSystemic Lupus ErythematosusUnited States
-
Daiichi Sankyo, Inc.Completed
-
Daiichi Sankyo, Inc.TerminatedMetastatic Colorectal CancerUnited States, Spain, Belgium, Japan, France, United Kingdom, Italy, Poland
-
Daiichi Sankyo, Inc.TerminatedAcute Myeloid LeukemiaUnited States
-
Daiichi Sankyo, Inc.TerminatedNon-small Cell Lung Cancer (NSCLC)Taiwan
-
Daiichi Sankyo, Inc.TerminatedMyelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States
-
Daiichi Sankyo, Inc.CompletedType 2 Diabetes MellitusUnited States, Germany, Mexico, Romania, Serbia, South Africa, Ukraine, Chile, Peru, Puerto Rico, Austria, Hungary, Slovakia, India, Czechia, Latvia, Argentina, United Kingdom
-
Daiichi Sankyo, Inc.Completed
-
Daiichi Sankyo, Inc.CompletedModerate Hepatic ImpairmentUnited States
-
Daiichi Sankyo, Inc.CompletedAtopic DermatitisUnited States
-
Daiichi Sankyo, Inc.CompletedMetastatic Colorectal CancerUnited States, Russian Federation, Germany, France, Italy
-
Daiichi Sankyo, Inc.CompletedBaseline Epidemiologic AssessmentUnited States